Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

This review discusses the epidemiology and available treatments for male androgenetic alopecia, noting that while current therapies can slow progression, they provide only partial hair restoration, and further research is needed for new strategies.

In this review, the authors examined the bioactive compounds in rosemary, noting its potential anti-inflammatory, antimicrobial, wound-healing, and anticancer activities, and highlighted its use in traditional medicine and cosmetics for conditions such as aging, baldness, and sun damage.

In this case report, the authors found that hair transplantation on a free microvascular flap may be a viable and effective option for achieving good aesthetic outcomes when treating residual alopecia following reconstruction of large scalp defects.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

This report describes two cases where lichen planopilaris may have compromised the hair follicles in both donor and recipient areas following follicular unit transplantation.

This report describes two cases of alopecia totalis treated with turban psoralen and sunlight exposure, but it provides no clinical outcome results.

This study reported that autologous hair transplantation is a safe and effective treatment for children with cicatricial alopecia, achieving an average hair survival rate of 85.3% and high satisfaction among family members, with minimal complications observed.

This case study describes a one-year-old female Pit Bull Terrier with alopecia X whose hair was fully restored after trilostane therapy addressed an adrenal sex hormone imbalance.

This review discusses female pattern hair loss, its psychological impact, and available treatments but provides no new clinical findings; the authors emphasize early intervention for better outcomes.

This study found that oral finasteride increased the total number of hairs in men with androgenetic alopecia by 55% over 2.5 years, but did not reduce the number of miniaturized vellus hairs.

This review discusses the growing problem of alopecia and suggests that homeopathy, alongside lifestyle changes, may effectively manage different types of hair loss, though it reports no new clinical findings.

This case report suggests that using encapsulated retinol in polylysine may effectively treat actinic keratosis with minimal irritation, potentially providing a safer alternative for frequent use.

This thesis reviews the psychological and social challenges faced by men and women with androgenetic alopecia who seek treatment, but reports no new results.

This study found no general elevation in androgen levels among men predisposed to balding, despite a correlation with the free-to-total testosterone ratio; no link was observed with acne.

In this study, researchers documented the first instance of alopecia in bats within the Puebla region, specifically affecting two Artibeus jamaicensis and one Choeronycteris mexicana, possibly linked to environmental stress from human activities interfering with their nutrition.

This study found that a dietary supplement containing L-cystine, medicinal yeast, and pantothenic acid significantly improved hair growth in women with telogen effluvium over six months compared to placebo.

In this study, researchers observed that follicular microinflammation significantly contributes to the early stages of male androgenetic alopecia, potentially leading to perifollicular fibrosis and follicle destruction as the condition progresses.

This study found that using 2% topical minoxidil before and after hair transplantation may improve graft outcomes by reducing initial shedding in patients with androgenetic alopecia.

This article reviews treatment options for male androgenetic alopecia, including minoxidil, 5 alpha reductase inhibitors, and hair transplantation, but reports no new clinical findings.

This study suggests that skin sections from 4-week-old C3H mice could serve as an in vitro model for human androgenic alopecia, as minoxidil partially reverses suppressed hair follicle elongation.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

This article discusses the potential beneficial effect of spironolactone on androgenic alopecia but provides no new clinical findings.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

This study found that 65.2% of female pattern hair loss patients showed significant hair growth improvement with a daily dosage of 2.5 mg finasteride, with better outcomes in patients with lower initial Ludwig scores and older age at onset.

This review discusses the evolution of scientific understanding and treatment approaches for androgenetic alopecia, from androgen metabolism to the potential of biologic response modifiers, reporting no new clinical findings.

This case report describes the first dermoscopic evaluation of alopecia areata-like disease in a dog, where the condition mirrored human cases in terms of clinical presentation and treatment response.

This study observed that good surgical outcomes for secondary cicatricial alopecia were achieved in 18 patients, with method selection influenced by the size, location, and shape of alopecia.

This article presents a case of giant cell arteritis occurring in a patient with de Quervain's thyroiditis but reports no new clinical findings.